Literature DB >> 6127470

Facilitation of tumour progression by cancer therapy.

R S Kerbel, A J Davies.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6127470     DOI： 10.1016/s0140-6736(82)90169-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Radiation enhancement of metastasis: a review.

Authors:  C F von Essen
Journal:  Clin Exp Metastasis       Date:  1991 Mar-Apr       Impact factor: 5.150

2.  Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin.

Authors:  S Choi; M Kobayashi; J Wang; H Habelhah; F Okada; J Hamada; T Moriuchi; Y Totsuka; M Hosokawa
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

Review 3.  Drug resistance and DNA repair.

Authors:  M Fox; J J Roberts
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 4.  Can cancer chemotherapy enhance the malignant behaviour of tumours?

Authors:  T J McMillan; I R Hart
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

5.  Characterization of MBT-2 tumour cell "variant" resistant to tumour necrosis factor.

Authors:  S A Kadhim; J Y Wang; B McLean; J L Chin
Journal:  Urol Res       Date:  1991

6.  Preventing diversification of malignant tumor cells during therapy.

Authors:  G L Nicolson; R Lotan
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

Review 7.  Immunology of metastasis. Can the immune response cope with disseminated tumor?

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

8.  Metastatic phenotype of human prostate tumor cells in athymic nude mice: alteration by exposure to ethyl methanesulfonate and "reversion" by 5-azacytidine.

Authors:  J L Ware; A P Lieberman; K S Webb
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

9.  Enhanced experimental metastatic capacity of a murine melanoma following pre-treatment with anticancer drugs.

Authors:  T J McMillan; I R Hart
Journal:  Clin Exp Metastasis       Date:  1986 Oct-Dec       Impact factor: 5.150

10.  The thirtieth annual meeting of the British Association for Cancer Research and the fourth annual meeting of the Association of Cancer Physicians. 10-12 April 1989, Glasgow, UK.

Authors: 
Journal:  Br J Cancer       Date:  1989-09       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.